中国医药导报
中國醫藥導報
중국의약도보
CHINA MEDICAL HERALD
2014年
22期
94-98,102
,共6页
中药%内分泌治疗%激素依赖型乳腺癌%作用机制
中藥%內分泌治療%激素依賴型乳腺癌%作用機製
중약%내분비치료%격소의뢰형유선암%작용궤제
Herbs%Endocrine-therapy%Hormone-dependent breast cancer%Mechanism
目的:探讨疏肝健脾养阴方联合内分泌治疗在激素依赖型乳腺癌中的作用和价值。方法将2010年7月~2012年12月在浙江省中医院或湖州市妇幼保健院治疗的136例患者分为四组院A组(绝经前,中药联合内分泌治疗,43例),B组(绝经前,单纯内分泌治疗,30例),C组(绝经后,中药联合内分泌治疗,36例)及D组(绝经后,单纯内分泌治疗,27例),随访记录相关指标,采用SPSS 17.0进行统计分析。结果 A、C组CA153、T抑制(CD3+/CD8+)、总胆固醇(CHOL)、谷氨酰转肽酶(GGT)及纤维蛋白原(FIB)均分别低于B、D组,T辅助/T抑制(CD4+/CD8+)分别高于B、D组,差异有统计学意义(P<0.05)。结论中药联合内分泌治疗激素依赖型乳腺癌,可提高临床疗效,减少毒副作用,值得临床进一步推广。
目的:探討疏肝健脾養陰方聯閤內分泌治療在激素依賴型乳腺癌中的作用和價值。方法將2010年7月~2012年12月在浙江省中醫院或湖州市婦幼保健院治療的136例患者分為四組院A組(絕經前,中藥聯閤內分泌治療,43例),B組(絕經前,單純內分泌治療,30例),C組(絕經後,中藥聯閤內分泌治療,36例)及D組(絕經後,單純內分泌治療,27例),隨訪記錄相關指標,採用SPSS 17.0進行統計分析。結果 A、C組CA153、T抑製(CD3+/CD8+)、總膽固醇(CHOL)、穀氨酰轉肽酶(GGT)及纖維蛋白原(FIB)均分彆低于B、D組,T輔助/T抑製(CD4+/CD8+)分彆高于B、D組,差異有統計學意義(P<0.05)。結論中藥聯閤內分泌治療激素依賴型乳腺癌,可提高臨床療效,減少毒副作用,值得臨床進一步推廣。
목적:탐토소간건비양음방연합내분비치료재격소의뢰형유선암중적작용화개치。방법장2010년7월~2012년12월재절강성중의원혹호주시부유보건원치료적136례환자분위사조원A조(절경전,중약연합내분비치료,43례),B조(절경전,단순내분비치료,30례),C조(절경후,중약연합내분비치료,36례)급D조(절경후,단순내분비치료,27례),수방기록상관지표,채용SPSS 17.0진행통계분석。결과 A、C조CA153、T억제(CD3+/CD8+)、총담고순(CHOL)、곡안선전태매(GGT)급섬유단백원(FIB)균분별저우B、D조,T보조/T억제(CD4+/CD8+)분별고우B、D조,차이유통계학의의(P<0.05)。결론중약연합내분비치료격소의뢰형유선암,가제고림상료효,감소독부작용,치득림상진일보추엄。
Objective To explore the action of Soothing Liver and Strengthening Spleen and Tonifying Yin Herb plus endocrine-therapy and the significance in treatment of hormone-dependent breast cancer. Methods 136 patients who were treated in Zhejiang Hospital of TCM or Huzhou Maternity & Child Care Hospital from July 2010 to December 2012 were divided into 4 groups: group A (premenopausal, herbs plus endocrine-therapy, n=43), group B (pre-menopausal, endocrine-therapy, n=30), group C (postmenopausal, herbs plus endocrine-therapy, n=36) and group D (postmenopausal, endocrine-therapy, n=27). Data was registered and analyzed by SPSS 17.0. Results CA153, CD3+/CD8+, CHOL, GGT and FIB of group A and group C were significantly reduced, while CD4+/CD8+was improved, com-pared with group B and group D (P< 0.05). Conclusion Herbs plus endocrine-therapy can significantly improve the clinical effects and alleviate side-effects, which is worth of promotion in clinic.